These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20043514)

  • 41. Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance.
    Hua HK; Jin C; Yang LJ; Tao SQ; Zhu XH
    Cell Biochem Biophys; 2015 Jun; 72(2):475-80. PubMed ID: 25575894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin.
    Kanitakis J; Hoyo E; Hermier C; Chouvet B; Thivolet J
    Cancer; 1992 Jun; 69(12):2937-41. PubMed ID: 1591687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma.
    Connolly M; Narayan S; Oxley J; de Berker DA
    Clin Exp Dermatol; 2008 Aug; 33(5):625-8. PubMed ID: 18616725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aggressive histological features of keratoacanthoma.
    Janecka IP; Wolff M; Crikelair GF; Cosman B
    J Cutan Pathol; 1977 Dec; 4(6):342-8. PubMed ID: 753852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases.
    Lonsdorf AS; Edelmann D; Albrecht T; Brobeil A; Labrenz J; Johanning M; Schlenk RF; Goeppert B; Enk AH; Toberer F
    Acta Derm Venereol; 2024 Feb; 104():adv13381. PubMed ID: 38323498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crater/ulcerated form of infundibular squamous cell carcinoma: A possible distinct entity as a malignant (or high-grade) counterpart to keratoacanthoma.
    Misago N; Inoue T; Nagase K; Tsuruta N; Tara-Hashimoto A; Kimura H; Takahara K; Narita T; Narisawa Y
    J Dermatol; 2015 Jul; 42(7):667-73. PubMed ID: 25854192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Facial keratoacanthoma.
    Patterson HC
    Otolaryngol Head Neck Surg; 1983 Jun; 91(3):263-70. PubMed ID: 6410326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
    Kossard S; Tan KB; Choy C
    Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.
    Basta-Juzbasić A; Klenkar S; Jakić-Razumović J; Pasić A; Loncarić D
    Acta Dermatovenerol Croat; 2004; 12(4):251-6. PubMed ID: 15588557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.
    Stephenson TJ; Royds JA; Bleehen SS; Silcocks PB; Rees RC
    Dermatology; 1993; 187(2):95-9. PubMed ID: 8358113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.
    Cribier B; Asch P; Grosshans E
    Dermatology; 1999; 199(3):208-12. PubMed ID: 10592399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Keratoacanthoma as a postoperative complication of skin cancer excision.
    Goldberg LH; Silapunt S; Beyrau KK; Peterson SR; Friedman PM; Alam M
    J Am Acad Dermatol; 2004 May; 50(5):753-8. PubMed ID: 15097960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Keratoacanthoma: when to observe and when to operate and the importance of accurate diagnosis.
    Netscher DT; Wigoda P; Green LK; Spira M
    South Med J; 1994 Dec; 87(12):1272-6. PubMed ID: 7973929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eosinophil infiltration in keratoacanthoma and squamous cell carcinoma of the skin.
    Lowe D; Fletcher CD; Shaw MP; McKee PH
    Histopathology; 1984 Jul; 8(4):619-25. PubMed ID: 6479904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Warts and epidermoid carcinoma after renal transplantation].
    Euvrard S; Chardonnet Y; Hermier C; Viac J; Thivolet J
    Ann Dermatol Venereol; 1989; 116(3):201-11. PubMed ID: 2545155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Subungual keratoacanthoma].
    Bräuninger W; Hoede N
    Hautarzt; 1986 May; 37(5):270-3. PubMed ID: 3733446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Squamous proliferations on the legs of women: Qualitative examination of histopathology, TP53 sequencing, and implications for diagnosis in a series of 30 cases.
    Ko CJ; Glusac EJ; McNiff JM; Rodic N; Leffell DJ
    J Am Acad Dermatol; 2017 Dec; 77(6):1126-1132.e1. PubMed ID: 28709693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
    Phillips P; Helm KF
    J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.